4至7.9小时之间的食后血葡萄糖可能是糖尿病潜在的诊断标志物
Yutang Wang1, Yan Fang1, Christopher L Aberson2
1Discipline of Life Science, Institute of Innovation, Science and Sustainability, Federation University Australia, Ballarat, VIC 3350, Australia.
Biomedicines
|June 27, 2024
概括
预测的食后葡萄糖 (PPG) 水平可以准确诊断糖尿病. 这种方法为糖尿病诊断提供了一个有希望的新方法,未来的研究可能需要175名参与者的样本大小.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 临床诊断 临床诊断 临床诊断
背景情况:
- 饭后葡萄糖 (PPG) 含量在进食后4 - 7.9小时内测量,与主要疾病的死亡率有关.
- 准确的PPG测量对于了解代谢健康和疾病风险至关重要.
研究的目的:
- 评估糖尿病预测PPG水平的诊断能力.
- 为了确定糖尿病诊断中预测PPG的准确性和最佳切断值.
主要方法:
- 用多重线性回归来开发PPG水平的预测模型在第一组 (4420名参与者).
- 开发的模型应用于第二组 (8422名参与者) 预测PPG水平.
- 接收器操作特征 (ROC) 曲线分析评估了预测的PPG的诊断性能.
主要成果:
- 在第一组80%的参与者中,PPG预测模型的准确度在11.1mg/dL内.
- 在第二组中,预测的PPG诊断糖尿病的准确率为87.3%,灵敏度为75.1%,在102.5 mg/dL的截止值下,特异性为84.1%.
- 模拟表明,未来研究所需的样本大小为175名参与者,其功率为80%.
结论:
- 预测的PPG水平显示出作为糖尿病诊断标志物的巨大潜力.
- 建议对至少175名参与者进行进一步的研究,以确认PPG的最终诊断价值.
- 这种预测方法可以提高糖尿病查和诊断方案.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Oral Hypoglycemic Agents: Glinides
152
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
152
Hypoglycemia and Glucagon
254
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
254
Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Dipeptidyl Peptidase 4 Inhibitors
180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180


